NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants
Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants
CompletedN/A
Sponsor: University of Alabama at Birmingham
Conditions: HIV Infections, Hiv
Interventions: Alere Q Testing
Countries: Zambia
The purpose of the study is to test the effect of the Alere™ q HIV-1/2 Detect (diagnostic assay) on uptake of HIV testing among HIV-exposed infants and young children, and health outcomes for HIV-infected infants and young children using a novel POC EID Community Model in Zambia. The study will also assess the feasibility of field implementation of this novel diagnostic tool and its acceptability among HIV-infected mothers and frontline health workers.
Eligibility overview
Sex: ALL
Age: 1 Minute to 17 Months
Healthy volunteers: No
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion criteria include IYCs: 1. 0 days (at birth) - 17 months of age; 2. Probable or known HIV exposure documented through maternal sero-positivity or reactive infant HIV antibody test; 3. The IYC must be born to mothers who: 1. attended ≥1 ANC visits without HIV testing; or 2. delivered at home and did not return for post-natal care at a health facility, and thus the mother or their child were not tested for HIV; or 3. were documented as HIV-infected but never initiated ART; or 4. disengaged from HIV care after ART initiation/have not returned for ARV refills; or 5. have not returned to the facility with their infant for initial EID testing or follow-up EID testing (after a negative test at birth or 6 weeks); or 6. IYC not tested 6 weeks after cessation of breastfeeding. 4. With a parent/guardian ≥18 years of age, and willing and able to provide written informed consent in a study language (English, Nyanja, or Bemba). Exclusion criteria include IYCs: 1. With documented age-appropriate, guideline-adherent receipt of DBS-based EID HIV PCR testing; 2. Already known to be HIV-infected / receiving ART.
Locations (6)
- Lusaka, Zambia
- Lusaka, Zambia
- Lusaka, Zambia
- Lusaka, Zambia
- Lusaka, Zambia
- Lusaka, Zambia